LaunchPad Focuses on Catalyzing Early Stage Research
University of California San Francisco
Give to UCSF
UCSF Researchers Develop Novel Methods to Observe Disease Processes
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
LaunchPad Focuses on Catalyzing Early Stage Research: Q&A with Ruben Rathnasingham
Ruben Rathnasingham, PhD, associate director of Early Translational Research at UCSF's Clinical and Translational Science Institute, is leading the team responsible for LaunchPad. In this Q&A, he discusses the project and how it can benefit researchers.
Cell Growth Discovery Has Implications for Targeting Cancer
The way cells divide to form new cells – to support growth, to repair damaged tissues, or simply to maintain our healthy adult functioning – is controlled in previously unsuspected ways, UCSF researchers have discovered.
Childbirth Not Significant Contributor to Later Sexual Dysfunction
Childbirth is not a major contributor to sexual dysfunction in women later in life, according to a new study led by UCSF researchers.
Whites More Prone to Certain Heart Condition than Other Ethnic Groups
An individual’s race or ethnic background could be a determining factor when it comes to risk of atrial fibrillation, the most frequently diagnosed type of irregular heart rhythm, according to researchers at UCSF.
Scientist Identifies Triple-Negative Breast Cancer Target for Drug Development
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
NIH Official Says Spending Cuts Pose Unprecedented Threat to Biomedical Research
Scientific progress and innovation are speeding along, faster than ever before, but arbitrary spending cuts are posing an unprecedented threat.
Six UCSF Researchers Win NIH Awards for High-Risk, High-Reward Work
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
UC Partnership Gets NIH Designation as Center to Improve Heart, Lung Health
A consortium of the five University of California medical campuses, including UCSF, has been awarded a $12 million grant and designated by the National Institutes of Health as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute.
New Hepatitis Virus was False Alarm, Likely a Lab Contaminant
The report earlier this year of a new hepatitis virus was a false alarm, according to UCSF researchers who correctly identified the virus as a contaminant present in a type of glassware used in many research labs.
Flame Retardants in Pregnant Women's Blood Drop After State Ban
A class of flame retardants that has been linked to learning difficulties in children has rapidly declined in pregnant women’s blood since the chemicals were banned in California a decade ago, according to a study led by researchers at UCSF.
NIH Deputy Director to Discuss Challenges to Biomedical Research in U.S.
Sally Rockey, deputy director for Extramural Research at the National Institutes of Health, is giving a talk titled “NIH: Interesting Times, Challenging Times” at UCSF on Tuesday, Sept. 24.
UCSF Awarded $20M Federal Grant on Tobacco Regulatory Sciences
UCSF will receive a five year, $20 million grant as part of a first-of-its-kind tobacco science regulatory program by the U.S. Food and Drug Administration and the National Institutes of Health.
Lifestyle Changes May Lengthen Telomeres, A Measure of Cell Aging
A small pilot study shows for the first time that changes in diet, exercise, stress management and social support may result in longer telomeres, the parts of chromosomes that affect aging.
